SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2377Shouldn't the scientists who did the work get the bonuses not pencil pushersrkrw-7/29/2010
2376From Jefferies, comments on Sanofi earnings call.... Thinks erosion curve for Lrkrw-7/29/2010
23752Q10 Annualized US Lovenox Sales: $2.7B (highest-ever quarter): siliconinvestorDewDiligence_on_SI-7/29/2010
2374Lovenox sales estimates before and after the generic launch. The numbers start arkrw-7/28/2010
2373Almost no volume or volatility in AH trading today... MNTA Momenta PharmaceuticIan@SI-7/28/2010
2372Yeah, I've since looked at that part, too. You are dead on that it is meanttuck-7/28/2010
2371Plavix?tom pope-7/28/2010
2370Brilanta AC: * JULY 28, 2010, 4:51 P.M. ET FDA Panel Backs Use Of AstraZeneIan@SI-7/28/2010
2369On the assumption that the Brilanta AC meeting must now be over, there is and haIan@SI17/28/2010
2368Plavix sales and forecast of changes with the trailing 6 zeros truncated.Ian@SI-7/28/2010
2367Pardon my ignorance, but what do those numbers represent? >eom<Jeffry K. Smith-7/28/2010
2366Here's the full section: <i>(2)(A) An abbreviated application for a nBiomaven-7/28/2010
2365Updated insider shareholdings: siliconinvestor.comDewDiligence_on_SI-7/28/2010
2364Not surprisingly more ATM selling after the news but aggressive. Ganesh: 60,00rkrw-7/28/2010
2363I replied to that in siliconinvestor.com . Regards, DewDewDiligence_on_SI-7/28/2010
2362Sanofi gets a little more specific with their lawsuit. Still looks like a long tuck-7/28/2010
2361"What exactly did Teva say? That they now comply, or they will be able to ctuck-7/28/2010
2360Is there overlap between MNTA's lovenox and its own M118?tom pope-7/28/2010
2359What exactly did Teva say? That they now comply, or they will be able to complyBiomaven27/28/2010
2358I think it's a stretch to think Teva will be sued if the FDA turns them downrkrw-7/28/2010
2357Peter, rkrw, Dew, Have you guys read the FDA response to the CP that came out tuck17/28/2010
2356It looks like he expects new approvals next year, late in the year. JonRobohogs-7/28/2010
2355Looks like at least 1 analyst has started to believe there will really be some sIan@SI-7/27/2010
2354MNTA ‘ReadMeFirst’ updated: <i>pricing of generic Lovenox (with musings bDewDiligence_on_SI-7/27/2010
2353The chances of the court interfering with the FDA's decision through grantinMichael Young-7/27/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News